Menu
Back to User profile » Dr Ming Zhao
Papers published by Dr Ming Zhao:
Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
Li G, Wang T, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M
Drug Design, Development and Therapy 2020, 14:2187-2197
Published Date: 3 June 2020
Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
Zhang X, Zhang Y, Wang Y, Wu J, Chen H, Zhao M, Peng S
International Journal of Nanomedicine 2020, 15:465-481
Published Date: 21 January 2020
13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein
Li G, Ren Y, Zhang X, Zhao S, Wang Y, Wu J, Peng S, Zhao M
OncoTargets and Therapy 2019, 12:10651-10662
Published Date: 5 December 2019
RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
Liu W, Mao Y, Zhang X, Wang Y, Wu J, Zhao S, Peng S, Zhao M
International Journal of Nanomedicine 2019, 14:7263-7279
Published Date: 6 September 2019
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
Zhao S, Li Z, Huang F, Wu J, Gui L, Zhang X, Wang Y, Wang X, Peng S, Zhao M
International Journal of Nanomedicine 2019, 14:4817-4831
Published Date: 3 July 2019
Dimethyl 2,2′-[2,2′-(ethane-1,1-diyl)bis(1H-indole-3,2-diyl)]-diacetate: a small molecule capable of nano-scale assembly, inhibiting venous thrombosis and inducing no bleeding side effect
Wang Y, Chen H, Zhang X, Gui L, Wu J, Feng Q, Peng S, Zhao M
International Journal of Nanomedicine 2018, 13:7835-7844
Published Date: 22 November 2018